There has been considerable interest in recent years in the relationship between immune responses to the hepatitis B surface antigen and the liver cell injury of acute type B hepatitis. Several lines of evidence suggest that the hepatitis B virus is not cytopathogenic and that liver damage may be the result of immune-mediated destruction of infected hepatocytes (Dudley et al., 1972a; Eddleston, 1976) . In almost all patients with acute hepatitis B infection a cell-mediated response to HBsAg can be demonstrated after recovery (Yeung Laiwah et al., 1973; Irwin et al., 1974; Reed et al., 1974) 
lipoprotein was undertaken in 21 adults with acute hepatitis type B. Cellular immunity to HBsAg as determined by leucocyte migration inhibition with partially purified HBsAg as antigen was detected in all the patients during the recovery phase of the illness and was already detectable at the time of admission in 13 (62%) of the cases. In five of the remaining eight the titre of HBsAg in the serum at this time was high and in the whole series there was an inverse correlation between the degree of migration inhibition on admission and the peak HBsAg titre suggesting that antigen or possibly antigen/antibody complexes might be interfering with the demonstration of cellular immunity in vitro. Using a combination of minimum migration index recorded during the recovery period and peak HBsAg titre, it was possible to compute the peak aspartate aminotransferase level with reasonable accuracy, a finding consistent with the hypothesis that the severity of the illness is related to both the number of infected hepatocytes and the vigour of the immune response to HBsAg. Evidence of an immune response to the liver-specific hepatocyte membrane lipoprotein was present in 50%0 of the patients tested at the time of admission, but was transient, having disappeared in every case by four weeks. The minimum migration index recorded with HBsAg as antigen was significantly lower in those with detectable sensitisation to the lipoprotein and it is possible that this autoimmune reaction is also generated by the interaction of T cells with viral antigenic determinants on the liver cell surface.
There has been considerable interest in recent years in the relationship between immune responses to the hepatitis B surface antigen and the liver cell injury of acute type B hepatitis. Several lines of evidence suggest that the hepatitis B virus is not cytopathogenic and that liver damage may be the result of immune-mediated destruction of infected hepatocytes (Dudley et al., 1972a; Eddleston, 1976) . In almost all patients with acute hepatitis B infection a cell-mediated response to HBsAg can be demonstrated after recovery (Yeung Laiwah et al., 1973; Irwin et al., 1974; Reed et al., 1974) , but there is consecutively over a six month period to an infectious disease hospital serving the inner London area were screened by immunodiffusion and electrophoresis for the presence of HBsAg. Twenty-three were found to be antigen positive, and further samples for immunological study were obtained from these twice weekly in hospital and weekly through the convalescence period. Two patients were lost to follow-up before antigen clearance had occurred and have been excluded from the study. In addition to complete history, physical examination, and daily clinical visits, serum aspartate aminotransferase (AST), alkaline phosphatase, and bilirubin levels were measured weekly.
IMMUNOLOGICAL STUDIES
Each serum sample was tested for HBsAg and antiHBs by immunodiffusion and immunoelectrophoresis (World Health Organisation, 1970) and radioimmunoassay (Reed et al., , 1974 . The titre of hepatitis B surface antigen was determined by complement fixation (Bradstreet and Taylor, 1962) . Serum autoantibodies reacting with smooth muscle were sought by indirect immunofluorescence (Doniach et al., 1966) initially and at two weeks and three months after admission.
PREPARATION OF ANTIGENS
Hepatitis B surface antigen Partially purified HBsAg was prepared from sera known to contain the antigen in high titre. Forty millilitre volumes were applied to a column (5 cm x 50 cm) containing Sepharose 6B equilibrated with *02 M phosphated-buffered saline (PBS) at pH 7-2.
The effluent was collected in 5 ml fractions and tested for HBsAg by a Latex agglutination technique (Pfizer Ltd). Antigen-positive fractions were concentrated by pressure filtration over a UM 10 membrane in a stirred cell (Dialaflo Ltd) and further purified by a second passage through Sepharose 6B. Fractions were again tested for HBsAg byLatex agglutination and those of highest titre were pooled, concentrated, and dialysed against PBS.
Eight different preparations were used in the present study, six being made from sera from healthy HBsAg carriers and two from sera from patients with chronic liver disease (the liver biopsy appearances were of chronic persistent hepatitis in one case and chronic aggressive hepatitis in the other). Before the introduction of a new batch, tests were performed with both new and old preparations in parallel to establish that there were no significant differences in their behaviour in the leucocyte migration test.
Liver-specific lipoprotein This antigen was prepared by sequential gel filtration of the 40 000 x g supernatant of a human liver homogenate as described elsewhere (Miller et al., 1972) and stabilised for storage at 4°C by adding 1 mM EDTA to the tris-HCI-NaCI buffer . Recent analyses including preparation of the apoproteinr have confirmed the homogeneous nature of this material and its localisation to the hepatocyte surface membrane (McFarlane et al., 1977) .
LEUCOCYTE MIGRATION TEST
A micromodification of the leucocyte migration technique was used with fetal calf serum selected for maximum sensitivity . The optimum concentration of partially purified HBsAg to be used in the test chambers was determined for each batch by constructing dose response curves using peripheral blood leucocytes obtained from healthy members of the laboratory staff whose immune status with regard to HBsAg was known from repeated tests of both cellular and humoral immunity (Reed et al., 1974) . At high concentrations all the antigen preparations produced toxic inhibition of leucocyte migration, while at much lower levels there was no inhibition of migration with leucocytes from any of the subjects tested. However, at optimum concentrations leucocytes from the immune individuals demonstrated inhibition of migration, while those of non-sensitised subjects did not. This concentration was then adopted for testing patients. The normal range for migration indices using HBsAg was found to be 0-80-1-10 and indices less than 0 80 were considered positive responses.
The same leucocyte migration technique was employed to detect cellular immunity to the liverspecific lipoprotein antigen. Using 50 ug of the lipoprotein to each millilitre of culture medium in the test chambers the normal range of migration indices (mean ± 2 SD in normal subjects) was 0-75-1*05 and any result outside this range was considered positive.
SPECIFICITY OF LEUCOCYTE MIGRATION
RESPONSE TO HBSAg On immune electron microscopy, the final preparation of partially purified HBsAg contained predominantly small round forms of HBsAg with some tubules, although occasional batches had a very small number of Dane particles. Free core material was never seen. In two of the recent preparations it has been possible to test for the presence of e antigen (El Sheikh et al., 1975) . This was detected in one of the samples from the patient with chronic persistent hepatitis but in the other, from a healthy carrier, the starting serum contained e antibody, and neither e antigen nor anti e could be detected in the preparation used in the leucocyte migration test. The results obtained with these two preparations in the leucocyte migration test were not significantly different in spite of the obvious differences in minor antigenic constituents. Control antigen preparations from HBsAg negative blood consistently gave negative results when used in the leucocyte migration test.
Results

NORMAL SUBJECTS
Serial observations of leucocyte migration with HBsAg as antigen were obtained in four members of the laboratory staff over a period of three months.
In three of them, observations had also been made one year previously (Reed et al., 1974) (Fig. 2) . Although the first six migration indices were within the normal range, the next seven observations, beginning 10 weeks after he joined the project, were clearly different, showing significant migration inhibition. Analysis of the results in this subject using the mean square successive difference test (Hart, 1942) confirmed the presence of a significant long-term non-random effect to reduce the migration indices (p < 0-05). Some six months later, anti HBs was first detected in the serum by radioimmunoassay but this change in reactivity was not accompanied by any clinical or biochemical evidence of acute hepatitis.
PATIENTS WITH HEPATITIS
Clinical data on the 17 men and four women with HBsAg-positive hepatitis is shown in Fig. 1 The results of leucocyte migration tests with HBsAg as antigen in four members of the laboratory staff studied repeatedly over a 12 week period. The horizontal dotted line indicates the lower limit of normal for the migration index. The results obtained in three of the individuals in a survey carried out one year previously (Reed et al., 1974) are also shown. The results obtained by using the leucocyte migration test with HBsAg as antigen, showed that inhibition of migration was already detectable at the time of admission in 13 (62%) of the patients (Table 2) . Of the eight patients in whom migration inhibition was not initially present, five had titres of HBsAg in the serum greater than 1/128 by complement fixation and for the whole group of 21 patients there was a significant correlation between the migration index at the time of admission and the peak titre of HBsAg (r + 0-51, p < 0 05). As the HBsAg level in the serum fell during recovery, migration inhibition was detected in all the patients, although the minimum migration index recorded varied considerably from case to case (range 0-38 to 0 75, There was also a difference between the groups in the frequency of antibodies reacting with smooth muscle antigens but this did not reach statistical significance (Table 3) .
Discussion
Although the HBsAg preparations used in the leucocyte migration test in the present study were only partially purified, the consistent results obtained with antigen preparations from many different samples of HBsAg positive blood and the completely negative results with control preparations made from normal serum suggested that HBsAg was the major antigenic constituent of the active preparations. These observations also suggested that HBsAg was responsible for the inhibition of leucocyte migration observed in the sensitised normal subjects and the patients studied. Thus the finding of migration inhibition in more than 60% of the patients when first tested supports the concept of immune-mediated liver cell damage in acute hepatitis. It has been suggested that the tissue damage is due to T lymphocytes reacting with HBsAg on the surface of infected hepatocytes and in support of this Alberti et al. (1975) , in a preliminary report, have identified membraneassociated HBsAg on a small proportion of hepatocytes isolated from liver biopsies taken soon after the onset of acute type B hepatitis. It is not possible from the present study to be sure that T lymphocytes alone are involved for, although the leucocyte migration test does seem in some experiments to be entirely T cell dependent (Fimmel, 1975) , there is also evidence suggesting that other cell types can release migration inhibitory factors (Rocklin et al., 1974) and even that circulating or cytophilic antibody can influence the result (Brostoff, 1974) . The finding of negative results initially on the leucocyte migration test in many of the patients with high titres of HBsAg suggested the possibility that antigen or antigen/antibody complexes were blocking T cell function. The significant correlation between peik HBsAg titre and initial migration index, and the appearance of migration inhibition in all cases when HBsAg levels fell, further supported this concept. Indeed, similar findings had also been obtained in an earlier study of cellular immunity to HBsAg in chronic hepatitis (Lee et al., 1975) . This situation may be similar to that proposed in patients and animals with extensive neoplastic disease where circulating tumour antigens or antigen/antibody complexes appear to block lymphocytes cytotoxic to tumour cells in vitro (Baldwin et al., 1973) .
Extensive washing of the lymphocytes often restores their cytotoxic potential (Currie and Basham, 1972) and it may be that differences in methods of preparing leucocytes and in antigen concentrations are responsible for the variation in the reported frequency of positive results in the leucocyte migration test with HBsAg as antigen in the early stages of acute hepatitis (Dudley et al., 1972b; Frei et al., 1973; Yeung Laiwah et al., 1973; Irwin et al., 1974; Ibrahim et al., 1975) . In vivo, this blocking effect might act to prevent T cell damage to infected hepatocytes and, while this could be important in the maintenance of infection in patients with chronic liver disease, it is probably irrelevant in acute hepatitis at the time of clinical presentation as immunofluorescent examination of liver biopsies usually shows that there are no remaining infected cells (Portmann et al., 1976) . We have not examined any patients in the incubation stage immediately before the onset of liver damage and it is entirely possible that the blocking effect does not occur until the virus infected hepatocytes begin to be destroyed, this also being the time when antigen/antibody complexes would begin to be formed.
If the theory of immunopathogenesis of viral hepatitis outlined earlier is correct, then the peak aspartate aminotransferase level in acute hepatitis, presumably reflecting the rapidity and extent of liver cell destruction, should be dependent on both the number of infected hepatocytes and the intensity of the immune attack. Although it is difficult to quantitate accurately either of these variables it is nevertheless of interest that it was possible to predict the aminotransferase level, with reasonable accuracy, from a combination of the peak titre of HBsAgwhich must, at least in part, reflect the number of infected cells-and the minimum migration index, which has been shown in other situations to correlate with the intensity of a delayed skin reaction (S0borg, 1967) .
The finding of migration inhibition with the liverspecific lipoprotein as antigen in half of the cases tested at presentation and its disappearance in the next few weeks is consistent with the suggestion that viral infection might temporarily stimulate a response to this membrane component. We have proposed that T lymphocytes reacting with membrane associated HBsAg could be responsible for stimulating autoreactive cells by exerting a 'helper effect' , and it was of interest that the only significant difference between those with and without detectable sensitisation to the lipoprotein was the intensity of the immune response to HBsAg, as reflected by the minimum migration index observed with this antigen. In a recent study lymphocyte cytotoxicity for isolated rabbit hepatocytes was detected in 13 of 14 patients with acute hepatitis tested within two weeks from the onset of their illness (Cochrane et al., 1976) and it may be that this is a more sensitive indicator of an immune response to the liver membrane lipoprotein (Thomson et al., 1974) .
